{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:17:39Z","timestamp":1771658259844,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008968","name":"National Research Council Sri Lanka","doi-asserted-by":"publisher","award":["NRC 09\/13"],"award-info":[{"award-number":["NRC 09\/13"]}],"id":[{"id":"10.13039\/100008968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\u03b2 thalassaemia intermedia (\u03b2TI) are a heterogeneous group of disorders known to be extremely phenotypically diverse. This group is more complex to manage as no definitive treatment guidelines exist unlike for \u03b2 thalassaemia major (\u03b2TM). There are only a few studies looking at genotype phenotype associations of \u03b2TI outside the Mediterranean region. The reasons for the diverse clinical phenotype in \u03b2TI are unknown. We categorized fifty Sri Lankan patients diagnosed with \u03b2TI as mild, moderate or severe according to published criteria. DNA samples were genotyped for \u03b2 thalassaemia mutations, \u03b1 globin genotype and copy number and known genetic modifiers of haemoglobin F production. There were 26\/50 (52.0%) in mild group and 12\/50 (24.0%) each in moderate and sever categories. 18\/26 (69.2%) classified as mild were \u03b2 heterozygotes and 17\/18 (94.4%) had excess \u03b1 globin genes. 11\/12 (91.6%) classified as moderate were \u03b2 heterozygotes and 8\/11 (72.2%) had excess \u03b1 globin genes. In contrast, 8\/12 (66.7%) classified as severe were \u03b2 homozygotes and 7\/8(87.5%) had \u03b1 globin gene deletions. In Sri Lanka, co-inheritance of either excess \u03b1 globin genes in \u03b2 thalassaemia heterozygotes or \u03b1 globin gene deletions in \u03b2 thalassaemia homozygotes is a significant factor in modulating disease severity.<\/jats:p>","DOI":"10.1038\/s41598-019-46674-y","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T10:03:41Z","timestamp":1562925821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Genotype-phenotype association analysis identifies the role of \u03b1 globin genes in modulating disease severity of \u03b2 thalassaemia intermedia in Sri Lanka"],"prefix":"10.1038","volume":"9","author":[{"given":"Shiromi","family":"Perera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishari","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menaka","family":"Hapugoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Nirmali","family":"Wickramarathne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indira","family":"Wijesiriwardena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitar G.","family":"Efremov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Weatherall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja","family":"Premawardhena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"46674_CR1","first-page":"704","volume":"79","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall, D. J. & Clegg, J. B. Inherited haemoglobin disorders: an increasing global health problem. Bull. World Health Organ. 79, 704\u2013712 (2001).","journal-title":"Bull. World Health Organ."},{"key":"46674_CR2","first-page":"649","volume":"90","author":"SL Thein","year":"2005","unstructured":"Thein, S. L. Genetic modifiers of \u03b2 thalassemia. Haematologica. 90, 649\u2013660 (2005).","journal-title":"Haematologica."},{"key":"46674_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/35066048","volume":"2","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall, D. J. Phenotype-Genotype relationship in monogenic disease:Lesson from the thalassemia. Nat. Rev. Genet. 2, 245\u2013255 (2001).","journal-title":"Nat. Rev. Genet."},{"key":"46674_CR4","first-page":"58","volume":"80","author":"C Camaschella","year":"1995","unstructured":"Camaschella, C. & Cappellini, M. D. Thalassemia intermedia. Haematologica. 80, 58\u201368 (1995).","journal-title":"Haematologica."},{"key":"46674_CR5","first-page":"1279","volume":"91","author":"I Panigrahi","year":"2006","unstructured":"Panigrahi, I. et al. Molecular characterization of thalassaemia intermedia in Indians. Haematologica. 91, 1279\u20131280 (2006).","journal-title":"Haematologica."},{"key":"46674_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2141.1983.tb02041.x","volume":"53","author":"JS Wainscoat","year":"1983","unstructured":"Wainscoat, J. S. et al. Thalassaemia intermedia in Cyprus: the interaction of \u03b1 and\/\u03b2 thalassaemia. Br. J. Haematol. 53, 411\u2013416 (1983).","journal-title":"Br. J. Haematol."},{"key":"46674_CR7","first-page":"1","volume":"11","author":"W Chen","year":"2010","unstructured":"Chen, W. et al. The molecular basis of beta thalassemia intermedia in Southern Chain: genotypic heterogeneity and phenotypic diversity. BMC Med. Genet. 11, 1\u201310 (2010).","journal-title":"BMC Med. Genet."},{"key":"46674_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1034\/j.1600-0609.2000.90087.x","volume":"64","author":"M Qatanani","year":"2000","unstructured":"Qatanani, M. et al. \u03b2 thalassaemia intermedia in Lebanon. Eu. J. Haematol. 64, 237\u2013244 (2000).","journal-title":"Eu. J. Haematol."},{"key":"46674_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ajh.2830480203","volume":"48","author":"C Camaschella","year":"1995","unstructured":"Camaschella, C., Mazza, U. & Roetto, A. Genetic interactions in thalassemia intermedia: analysis of beta-mutations, alpha-genotype, gamma-promoters and beta-LCR hypersensitive sites 2 and 4 in Italian patients. Am. J. Hematol. 48, 82\u201387 (1995).","journal-title":"Am. J. Hematol."},{"key":"46674_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/(SICI)1096-8652(199701)54:1<16::AID-AJH3>3.0.CO;2-7","volume":"54","author":"D Rund","year":"1997","unstructured":"Rund, D. et al. A. Genetic analysis of \u03b2-thalassemia intermedia in Israel: Diversity of Mechanisms and Unpredictability of Phenotype. Am. J. Hematol. 54, 16\u201322 (1997).","journal-title":"Am. J. Hematol."},{"key":"46674_CR11","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(99)08246-X","volume":"355","author":"S de Silva","year":"2000","unstructured":"de Silva, S. et al. Thalassaemia in Sri Lanka: Implications for the future health burden of Asian populations. Lancet. 355, 786\u2013791 (2000).","journal-title":"Lancet."},{"key":"46674_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1081\/HEM-100107877","volume":"25","author":"JM Old","year":"2001","unstructured":"Old, J. M. et al. A multi-center study in order to further define the molecular basis of b-thalassaemia in Thailand, Pakistan Sri Lanka, Mauritius, Syria and India and to develop a simple molecular diagnostic strategy by amplification refractory mutation systempolymerase chain reaction. Hemoglobin. 25, 397\u2013407 (2001).","journal-title":"Hemoglobin."},{"key":"46674_CR13","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.1365-2141.2003.04346.x","volume":"121","author":"CA Fisher","year":"2003","unstructured":"Fisher, C. A. et al. The molecular basis for the thalassaemias in Sri Lanka. Br. J. Haematol. 121, 662\u2013671 (2003).","journal-title":"Br. J. Haematol."},{"key":"46674_CR14","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(05)67396-5","volume":"366","author":"A Premawardhena","year":"2005","unstructured":"Premawardhena, A. et al. Haemoglobin E \u03b2 thalassemia in Sri Lanka. Lancet. 366, 1467\u20131470 (2005).","journal-title":"Lancet."},{"key":"46674_CR15","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1182\/blood-2005-02-0593","volume":"106","author":"A Premawardhena","year":"2005","unstructured":"Premawardhena, A. et al. A novel molecular basis for \u03b2 thalassemia intermedia poses new question about its pathophysiolgy. Blood. 106, 3251\u20133255 (2005).","journal-title":"Blood."},{"key":"46674_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1046\/j.1365-2141.1998.00519.x","volume":"100","author":"PJ Ho","year":"1998","unstructured":"Ho, P. J., Hall, G. W., Luo, L. Y., Weatherall, D. J. & Thein, S. L. Beta-thalassaemia intermedia: is it possible consistently to predict phenotype from genotype? Br. J. Haematol. 100, 70\u201378 (1998).","journal-title":"Br. J. Haematol."},{"key":"46674_CR17","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","volume":"115","author":"AT Taher","year":"2010","unstructured":"Taher, A. T. et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 115, 1886\u20131892 (2010).","journal-title":"Blood."},{"key":"46674_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1089\/gte.2008.0018","volume":"12","author":"M Neishabury","year":"2008","unstructured":"Neishabury, M. et al. Molecular Mechanisms underlyning thalassaemia Intermedia in Iran. Genet. Test. 12, 549\u2013556 (2008).","journal-title":"Genet. Test."},{"key":"46674_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/262853","volume":"2014","author":"Nasir A. S. Al-Allawi","year":"2014","unstructured":"Al-Allawi, N. A. S., Jalal, S. D., Mohammad, A. M., Omer, S. Q. & Markous, R. S. D. \u03b2-Thalassemia Intermedia in Northern Iraq: A Single Center Experience. Biomed. Res. Int., https:\/\/doi.org\/10.1155\/2014\/262853 (2014).","journal-title":"BioMed Research International"},{"key":"46674_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/03630269.2014.1002136","volume":"39","author":"J Khan","year":"2015","unstructured":"Khan, J., Ahmad, N., Siraj, S. & Hoti, N. Genetic Determinants of \u03b2-Thalassemia Intermedia in Pakistan. Hemoglobin. 39, 95\u2013101 (2015).","journal-title":"Hemoglobin."},{"key":"46674_CR21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V74.2.823.823","volume":"74","author":"A Galanello","year":"1989","unstructured":"Galanello, A. et al. Molecualr analysis of \u03b2\u00b0 Thalassemia Intermedia in Sardinia. Blood. 74, 823\u2013827 (1989).","journal-title":"Blood."},{"key":"46674_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3109\/03630269.2014.992530","volume":"39","author":"PS Perera","year":"2015","unstructured":"Perera, P. S. et al. Rare Hemoglobin Variants: Hb G-Szuhu (HBB: c.[243C\u2009>\u2009G]), Hb G-Coushatta (HBB: c.68A\u2009>\u2009C) and Hb Mizuho (HBB: c.206T\u2009>\u2009C) in Sri Lankan Families. Hemoglobin. 39, 62\u201365 (2015).","journal-title":"Hemoglobin."},{"key":"46674_CR23","unstructured":"Bain, B. J., Bates, I., Laffan, M. A. & Lewis, S. M. Dacie and Lewis Practical Haematology (Elsevier, 2016)."},{"key":"46674_CR24","unstructured":"Old, J. M. & Higgs, D. R. The Thalassaemias in Methods in Hematology (ed. Weatherall, D. J.) 74\u2013102 (Churchill Livingstone, 1983)."},{"key":"46674_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1309\/AJCP7HQ2KWGHECIO","volume":"133","author":"OTM Chan","year":"2010","unstructured":"Chan, O. T. M., Westover, K. D., Dietz, L., Zehnder, J. L. & Schrijver, I. Comprehensive and efficient HBB mutation analysis for detection of beta-hemoglobinopathies in a pan-ethnic population. Am. J. Clin. Pathol. 133, 700\u2013707 (2010).","journal-title":"Am. J. Clin. Pathol."},{"key":"46674_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/03630260802341687","volume":"32","author":"A Nadkarni","year":"2008","unstructured":"Nadkarni, A. et al. Moleculaar Characterization of \u03b4\u03b2- Thalassemia and Heriditary Persistant of Fetal Hemoglobin in the Indian Populaton. Hemoglobin. 32, 425\u2013433 (2008).","journal-title":"Hemoglobin."},{"key":"46674_CR27","doi-asserted-by":"crossref","unstructured":"Old, J. M. Haemoglobinopathies: Community Clues to Mutation Detection in Methods in Molecular Medicine: Diagnosis of Genetic Diseases (eds Elles, R. & Mountfold, R.) 169\u2013183 (Humana Press Inc, 1996).","DOI":"10.1385\/0-89603-346-5:169"},{"key":"46674_CR28","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3109\/08880018.2011.616573","volume":"28","author":"Y He","year":"2011","unstructured":"He, Y., Lin, W. & Luo, J. Influences of Genetic Variation on Fetal Hemoglobin. Pediatr. Hematol. Oncol. 28, 708\u2013717 (2011).","journal-title":"Pediatr. Hematol. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46674-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46674-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46674-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:25:51Z","timestamp":1671276351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46674-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["46674"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-46674-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"5 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10116"}}